Ingen Technologies Introduces OxyView(TM)
CALIMESA, Calif., July 27, 2005 /PRNewswire-FirstCall via COMTEX/ -- Ingen Technologies, Inc. (OTC: IGTN), the medical device manufacturer of OxyAlert(TM) and Secure Balance(TM), announces its new OxyView(TM) oxygen-monitoring medical product. "This innovative device is estimated to possess a $450 million annual revenue potential over the next few years, assuming it captures a 30% market share which we consider to be an attainable objective," said William Walling, Certified Financial Analyst.
The Company, with completed audits and just weeks away from moving to the OTCBB, has completed the research and development of OxyView(TM). This product enhances the safety, assurance and accuracy of hospitalized patients being administered oxygen from any source. OxyView(TM) is a lightweight pneumatic gauge that is attached to the oxygen tubing just below the neck. It informs the nursing staff of the oxygen flow rate at the site of the patient and can also immediately indicate the presence of any leak or inaccuracy between the delivery source and the patient.
Donn Harms, Esq., a San Diego-based patent attorney, has recently filed for U.S. patents on this unique technology for Ingen. Scott Sand, Ingen CEO & Chairman, commented: "As simple as it sounds, there is nothing in the hospital industry presently that competes with OxyView(TM). Currently, the hospital staff assumes that the flow rate near the patient is sufficient without any verification. In today's medical industry where malpractice and liability is a more serious issue, OxyView(TM) enhances safety and can reduce liabilities associated with equipment failure."
There are over 20 million patients each year that receive oxygen during hospitalization. The OxyView(TM) retail price is $75, and this device is a consumable item. The Company has engaged RC Product Development & Engineering in Corona, CA to build the unit. "This device is completely pneumatic and extremely accurate. We will have production of the unit ready in three months," said Richard Campbell, President of RC Product Development & Engineering.
Scott Sand, CEO & Chairman, added: "Ingen Technologies is now even more strongly positioned to deliver improving financial results, including earnings, and increasing value to its shareholders. And, it is important for investors to recognize that the incremental revenues expected to be derived from OxyView(TM) as it achieves market penetration are in addition to the $30 million of revenues anticipated to be generated from sales of OxyAlert(TM) in 2006, as announced earlier this month."
About Ingen Technologies
Ingen Technologies (OTC: IGTN), in business since 1999, is a medical device manufacturer and service provider for medical and consumer markets both domestic and abroad. Increasing revenues are generated from the Company's Secure Balance(TM) program; a medical product line for physicians and hospitals that provides patient services for "balance & fall prevention" programs. The OxyAlert(TM) is another product line: it has two U.S. patents and is clearly a proprietary technology. This product is the second generation development of the Company's initial BAFI(TM) product; a medical safety device that provides wireless and remote monitoring of oxygen delivery systems for patients and small aircraft. Using the same patented and proprietary technology, the Company also offers the GasAlert(TM) product; a device that interfaces between any gas line and accessory, such as a water heater, dryer, stove or heater, to detect leaks. This is a mass consumer item expected to go to market in 2005.
"Our team of professionals has developed our medical products principally for the ever-increasing elderly population. Our products are superior to any of our competition and they allow for effective medical product availability to seniors, whose growing numbers can provide a strong basis for a steady growth in sales and profits for our Company," said Scott Sand, CEO & Chairman of Ingen Technologies.
For more information, visit www.ingen-tech.com
Investor Relations Contact: Scott R. Sand, C.E.O & Chairman
Ingen Technologies, Inc.
285 E. County Line Road
Calimesa, CA 92320
800-259-9622
951-675-3266
800-777-1186 FAX
scottsand@ingen-tech.com
SOURCE Ingen Technologies, Inc.
Scott R. Sand, C.E.O & Chairman of Ingen Technologies, Inc., +1-800-259-9622, or
+1-951-675-3266, or fax, +1-800-777-1186, scottsand@ingen-tech.com
. |
